OCULIS-1006x250.png
Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology
17 oct. 2022 09h03 HE | Oculis
Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology Oculis is...
Arogo Capital Acquisition Corp. Enters Into Business Combination Agreement with EON Reality Inc., a Leading Virtual and Augmented Reality and Knowledge Metaverse Company
26 avr. 2022 07h30 HE | Arogo Capital Acquisition Corp.
EON Reality, Inc. Will  Become a Public Company Listed on NASDAQ Under the Name EON Reality, Inc. Transaction solidifies EON Reality Inc.’s (“EON Reality”) position as a leading global provider of...